Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 16INDUSTRY 3OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Gastrointestinal 1

Conditions

Anemia 2Pancreatic Neoplasms 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × ferric carboxymaltose × Clear all
NCT02628860 2020-04-28

FCM

National Cancer Center, Korea

Phase 2 Completed
40 enrolled
Classical hematologyGastrointestinal

Anemia, Pancreatic Neoplasms

NCT01725789 2016-12-16

Ferinject® Assessment In GastRectomy Patients With Acute Isovolemic Anemia (FAIRY)

National Cancer Center, Korea

Phase 3 Completed
454 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡